James Lambert
Breast cancer is a heterogeneous disease with various subtypes that exhibit distinct biological behaviors and clinical outcomes. Immunohistochemical (IHC) profiling is a critical tool in the classification of breast cancer subtypes, influencing treatment strategies and predicting patient prognosis. This study aims to evaluate the immunohistochemical profiles of breast cancer subtypes and their correlation with clinical outcomes, including response to therapy, recurrence and overall survival.
Поделиться этой статьей
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi 